Multigene panel testing and breast cancer risk: Is it time to scale down?

Elias I. Obeid; Michael J. Hall; Mary B. Daly

doi:10.1001/jamaoncol.2017.0342

Multigene panel testing and breast cancer risk: Is it time to scale down?

Elias I. Obeid
, Michael J. Hall
, Mary B. Daly

Fox Chase Cancer Center

Research output: Contribution to journal › Editorial

10 Scopus citations

Original language	English
Pages (from-to)	1176-1177
Number of pages	2
Journal	JAMA Oncology
Volume	3
Issue number	9
DOIs	https://doi.org/10.1001/jamaoncol.2017.0342
State	Published - Sep 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1001/jamaoncol.2017.0342

Cite this

@article{dd15845236874988a03872ceb5708abe,

title = "Multigene panel testing and breast cancer risk: Is it time to scale down?",

author = "Obeid, \{Elias I.\} and Hall, \{Michael J.\} and Daly, \{Mary B.\}",

year = "2017",

month = sep,

doi = "10.1001/jamaoncol.2017.0342",

language = "English",

volume = "3",

pages = "1176--1177",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Multigene panel testing and breast cancer risk

T2 - Is it time to scale down?

AU - Obeid, Elias I.

AU - Hall, Michael J.

AU - Daly, Mary B.

PY - 2017/9

Y1 - 2017/9

UR - https://www.scopus.com/pages/publications/85032631375

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000410676400007&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1001/jamaoncol.2017.0342

DO - 10.1001/jamaoncol.2017.0342

M3 - Editorial

C2 - 28418452

SN - 2374-2437

VL - 3

SP - 1176

EP - 1177

JO - JAMA Oncology

JF - JAMA Oncology

IS - 9

ER -

Multigene panel testing and breast cancer risk: Is it time to scale down?

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this